KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Return on Capital Employed: 2010-2025

Historic Return on Capital Employed for Novavax (NVAX) over the last 14 years, with Sep 2025 value amounting to 0.37%.

  • Novavax's Return on Capital Employed rose 89.00% to 0.37% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.37%, marking a year-over-year increase of 89.00%. This contributed to the annual value of -0.47% for FY2024, which is 97.00% up from last year.
  • As of Q3 2025, Novavax's Return on Capital Employed stood at 0.37%, which was down 2.24% from 0.38% recorded in Q2 2025.
  • Novavax's Return on Capital Employed's 5-year high stood at 64.22% during Q1 2023, with a 5-year trough of -35.67% in Q2 2023.
  • In the last 3 years, Novavax's Return on Capital Employed had a median value of -0.52% in 2024 and averaged 1.66%.
  • Per our database at Business Quant, Novavax's Return on Capital Employed skyrocketed by 6,707bps in 2023 and then crashed by 6,474bps in 2024.
  • Quarterly analysis of 5 years shows Novavax's Return on Capital Employed stood at -9.32% in 2021, then skyrocketed by 1,259bps to 3.27% in 2022, then tumbled by 942bps to -6.15% in 2023, then soared by 563bps to -0.52% in 2024, then spiked by 89bps to 0.37% in 2025.
  • Its Return on Capital Employed stands at 0.37% for Q3 2025, versus 0.38% for Q2 2025 and 0.41% for Q1 2025.